Maksim Khotimchenko

Dr. Maksim Khotimchenko

VeriSIM LIfe
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Carbohydrate Polymers
Verified
Journal Article
Closed access
MKMaksim Khotimchenko
Maksim Khotimchenko
Vladlena A TiastoVladlena A Tiasto
Vladlena A Tiasto
AKAleksandra Kalitnik
Aleksandra Kalitnik
MBMaria Begun
Maria Begun
RKRodion Khotimchenko
Rodion Khotimchenko
YKYuri Khotimchenko
Yuri Khotimchenko

1 September 2020 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MKMaksim Khotimchenko
Maksim Khotimchenko

1 November 2007 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
MKMaksim Khotimchenko
Maksim Khotimchenko
VKValeri Kovalev
Valeri Kovalev
YKYuri Khotimchenko
Yuri Khotimchenko

1 July 2008 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
MKMaksim Khotimchenko
Maksim Khotimchenko
EKE.A. Kolenchenko
E.A. Kolenchenko
YKY.S. Khotimchenko
Y.S. Khotimchenko

3 November 2016 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
ATAnna Tyrtyshnaia
Anna Tyrtyshnaia
LLLarisa V. Lysenko
Larisa V. Lysenko
FMFrancisco Madamba
Francisco Madamba
IMIgor V. Manzhulo
Igor V. Manzhulo
MKMaksim Khotimchenko
Maksim Khotimchenko
AKAlexander M. Kleschevnikov
Alexander M. Kleschevnikov
Maintaining pH levels within the physiological norm is an important component of brain homeostasis. However, in some pathological or physiological conditions, the capacity of the pH regulatory system could be overpowered by various factors resulting in a transient or permanent alteration in pH levels. Such changes are often observed in pathological conditions associated with neuroinflammation. We hypothesized that neuroinflammation itself is a factor affecting pH levels in neural tissue. To assess this hypothesis, we examined the effects of acute LPS-induced neuroinflammation on intra- and extracellular pH (pHi and pHo) levels in the CA1 region of mouse hippocampus. Acute neuroinflammation was induced using two approaches: (1) in vivo by i.p. injections of LPS (5 mg/kg) and (2) in vitro by incubating hippocampal slices of naïve animals in the LPS-containing media (1 μg/mL, 1 h at 35 °C). Standard techniques were used to prepare hippocampal slices. pHi was measured using ratiometric pH-sensitive fluorescent dye BCECF-AM. pHo was assessed using calibrated pH-sensitive micropipettes. The presence of neuroinflammation was verified with immunohistochemistry (IL-1β and Iba1) and ELISA (IL-1β and TNF-α). A significant reduction of pHi was observed in the slices of the LPS-injected 3-month-old (LPS 7.13 ± 0.03; Sal 7.22 ± 0.03; p = 0.043, r = 0.43) and 19-month-old (LPS 6.78 ± 0.08; Sal 7.13 ± 0.03; p = 0.0001, r = 0.32) mice. In contrast, the levels of pHo within the slice, measured in 19-month-old animals, were not affected (LPS 7.27 ± 0.02; Sal 7.26 ± 0.02; p = 0.6, r = 0.13). A reduction of pHi was also observed in the LPS-treated slices during the interval 3.5–7 h after the LPS exposure (LPS 6.92 ± 0.07; Veh 7.28 ± 0.05; p = 0.0001, r = 0.46). Acute LPS-induced neuroinflammation results in a significant intracellular acidification of the CA1 neurons in mouse hippocampus, while the pHo remains largely unchanged. Such changes may represent a specific protective reaction of neural tissue in unfavorable external conditions or be a part of the pathological process.

21 April 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DWDaniel Walden
Daniel Walden
MKMaksim Khotimchenko
Maksim Khotimchenko
HHHypatia Hou
Hypatia Hou
KCKaushik Chakravarty
Kaushik Chakravarty
JVJyotika Varshney
Jyotika Varshney
Fluoroquinolones (FQs) are a widespread class of broad-spectrum antibiotics prescribed as a first line of defense, and, in some cases, as the only treatment against bacterial infection. However, when administered orally, reduced absorption and bioavailability can occur due to chelation in the gastrointestinal tract (GIT) with multivalent metal cations acquired from diet, coadministered compounds (sucralfate, didanosine), or drug formulation. Predicting the extent to which this interaction reduces in vivo antibiotic absorption and systemic exposure remains desirable yet challenging. In this study, we focus on quinolone interactions with magnesium, calcium and aluminum as found in dietary supplements, antacids (Maalox) orally administered therapies (sucralfate, didanosine). The effect of FQ–metal complexation on absorption rate was investigated through a combined molecular and pharmacokinetic (PK) modeling study. Quantum mechanical calculations elucidated FQ–metal binding energies, which were leveraged to predict the magnitude of reduced bioavailability via a quantitative structure–property relationship (QSPR). This work will help inform clinical FQ formulation design, alert to possible dietary effects, and shed light on drug–drug interactions resulting from coadministration at an earlier stage in the drug development pipeline.